What is the recommended dilution rate for peripheral noradrenaline (norepinephrine) administration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dilution Rate for Peripheral Noradrenaline Administration

For peripheral administration of noradrenaline (norepinephrine), the recommended dilution is 4 mg in 1,000 mL of 5% Dextrose Injection or Sodium Chloride Injection containing 5% dextrose, yielding a concentration of 4 mcg/mL. 1

Standard Dilution Protocol

  • Add the content of one norepinephrine vial (4 mg in 4 mL) to 1,000 mL of 5% Dextrose Injection or Sodium Chloride Injection containing 5% dextrose to produce a 4 mcg/mL dilution 1
  • Dextrose in the solution reduces loss of potency due to oxidation 1
  • Administration in saline solution alone is not recommended 1
  • Higher concentration solutions may be used in patients requiring fluid restriction 1

Administration Considerations

  • Infuse norepinephrine into a large vein to minimize risk of extravasation 1
  • Avoid infusions into the veins of the leg in elderly patients or those with occlusive vascular disease 1
  • Avoid using a catheter-tie-in technique 1
  • Prior to use, the diluted solution can be stored for up to 24 hours at room temperature (20°C to 25°C) and should be protected from light 1

Dosing Guidelines

  • Initial dosage: 8 to 12 mcg per minute via intravenous infusion 1
  • Typical maintenance dosage: 2 to 4 mcg per minute 1
  • Monitor blood pressure every two minutes until desired hemodynamic effect is achieved, then every five minutes for the duration of the infusion 1
  • When discontinuing the infusion, reduce the flow rate gradually to avoid abrupt withdrawal 1

Special Considerations for Peripheral Administration

  • Peripheral infusions of norepinephrine can be a safe option in early resuscitation when following appropriate guidelines 2
  • Using standard concentrations reduces the risk of errors 2
  • 0.9% saline is recommended as the default diluent for peripheral norepinephrine 2
  • Implementation of a protocol for peripheral administration can safely reduce central venous catheter use 3

Precautions and Monitoring

  • Correct hypovolemia before initiating norepinephrine therapy 1
  • Visually inspect the solution for particulate matter and discoloration prior to administration (solution should be colorless) 1
  • Do not use if the solution is pinkish or darker than slightly yellow or if it contains a precipitate 1
  • Monitor for signs of extravasation, which can result in severe skin injury 1
  • Phentolamine (0.1-0.2 mg/kg up to 10 mg diluted in 10 mL of 0.9% sodium chloride) injected intradermally at the extravasation site may help counteract dermal vasoconstriction 4

Alternative Dilutions for Specific Situations

  • For anaphylaxis requiring continuous infusion: An alternative 1:100,000 solution (1 mg in 100 mL saline) can be prepared and administered at an initial rate of 30 to 100 mL/h (5-15 mcg/min), titrated based on clinical response 4
  • For pediatric patients: The "rule of 6" can be used - 0.6 × body weight (kg) = number of milligrams diluted to total 100 mL of saline; then 1 mL/h delivers 0.1 mcg/kg/min 4

Pediatric Considerations

  • Pediatric dosing typically ranges from 0.1-1.0 mcg/kg per minute, starting at the lowest dose and titrating to desired clinical effect 4
  • Doses as high as 5 mcg/kg per minute are sometimes necessary in children 4
  • Studies suggest that peripheral administration of norepinephrine in children can be carried out without obvious complications when proper protocols are followed 2, 5

References

Research

[Translated article] Safe administration of noradrenaline by the peripheral route: A systematic review.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.